C
Cristian Berce
Researcher at Iuliu Hațieganu University of Medicine and Pharmacy
Publications - 60
Citations - 864
Cristian Berce is an academic researcher from Iuliu Hațieganu University of Medicine and Pharmacy. The author has contributed to research in topics: Osseointegration & Transplantation. The author has an hindex of 13, co-authored 60 publications receiving 649 citations.
Papers
More filters
Journal ArticleDOI
Current methods of preventing aseptic loosening and improving osseointegration of titanium implants in cementless total hip arthroplasty: a review:
TL;DR: Patients’ optimization of obesity, osteoporosis, cardiovascular disease, psychotic disorders, and smoking cessation are associated with a higher survival of implants, and patients’ knowledge of the factors mentioned above is important for preventing aseptic loosening.
Journal ArticleDOI
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.
Florin Zaharie,Mihai-Stefan Muresan,Bobe Petrushev,Cristian Berce,Grigore-Aristide Gafencu,Sonia Selicean,Ancuta Jurj,Roxana Cojocneanu-Petric,Cosmin-Ioan Lisencu,Laura-Ancuta Pop,Valentina Pileczki,Dan Tudor Eniu,Mihai-Andrei Muresan,Roxana Zaharie,Ioana Berindan-Neagoe,Ciprian Tomuleasa,Alexandru Irimie +16 more
TL;DR: New data are brought to the forefront that suggest miR-375 as a new player in controlling the pathways responsible for inhibiting the natural history of CRC tumor cells, via the Bcl-2 pathway.
Journal ArticleDOI
How to Diagnose and Treat a Cancer of Unknown Primary Site.
Ciprian Tomuleasa,Florin Zaharie,Mihai-Stefan Muresan,Laura Pop,Zsolt Fekete,Delia Dima,Ioana Frinc,Adrian P. Trifa,Cristian Berce,Ancuta Jurj,Ioana Berindan-Neagoe,Mihnea Zdrenghea +11 more
TL;DR: Both the diagnostic challenges for patients with a cancer of unknown primary site as well as the current available therapeutic options are summarized, with emphasis on the management of this unique disease entity.
Journal ArticleDOI
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
Bobe Petrushev,Sanda Boca,Timea Simon,Cristian Berce,Ioana Frinc,Delia Dima,Sonia Selicean,Grigore-Aristide Gafencu,Alina Tanase,Mihnea Zdrenghea,Adrian Florea,Sorina Suarasan,Liana Dima,Raluca Stanciu,Ancuta Jurj,Anca Dana Buzoianu,Andrei Cucuianu,Simion Astilean,Alexandru Irimie,Ciprian Tomuleasa,Ioana Berindan-Neagoe +20 more
TL;DR: The effective transmembrane delivery and increased efficacy validate its use as a potential therapeutic in conjugation of TKIs onto spherical gold nanoparticles.
Journal ArticleDOI
Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
Ciprian Tomuleasa,Shigeo Fuji,Cristian Berce,Anca Onaciu,Sergiu Chira,Bobe Petrushev,Wilhelm-Thomas Micu,Vlad Moisoiu,Ciprian Osan,Catalin Constantinescu,Sergiu Pasca,Ancuta Jurj,Laura Pop,Ioana Berindan-Neagoe,Delia Dima,Shigehisa Kitano +15 more
TL;DR: The main present-day knowledge on the standard of care for acute lymphoblastic leukemia is presented and current knowledge is presented about the use of CAR T-cells in cancer immunotherapy, describing their design, the molecular constructs, and the preclinical data on murine models to properly explain the background for their clinical use.